[Upcoming Lecture] Antimicrobial Resistance (AMR) Seminar: Lessons from Semmelweis (Japan Medical Association office, Tokyo, Bunkyo-ku, November 22, 2019)
date : 11/5/2019
![[Upcoming Lecture] Antimicrobial Resistance (AMR) Seminar: Lessons from Semmelweis (Japan Medical Association office, Tokyo, Bunkyo-ku, November 22, 2019)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-86.jpg)
HGPI and its co-hosts the Japan Pharmaceutical Manufacturers Association(JPMA) and Japan Medical Association (JMA) will host a lecture aimed at healthcare providers, representatives from the government, and members of civil society entitled “Antimicrobial Resistance (AMR) Seminar: Lessons from Semmelweis.”
HGPI Chairman Dr. Kiyoshi Kurokawa will speak on the theme “The History of Infectious Disease and Current Challenges – Lessons from the Teachings of Semmelweis” and Adjunct Fellow Ms. Kaoru Matsuzawa and HGPI Board Member and CEO Mr. Ryoji Noritake will serve as moderators for a panel discussion.
■Program
Date & Time: Friday, November 22, 2019, 14:00-17:00 (Doors open at 13:30)
Venue: Japan Medical Association Office , Small Auditorium
Participation fee: Free
Capacity: 200 people
For program details, please see the PDF linked below.
To register, please fax or mail the registration form included in the PDF. To register online, please see the AMR Seminar website.
*It can be accessed in Japanese.
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-17
[Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March, 17, 2025)
-
2025-03-17
[Announcement] HGPI Participates in the WHO Civil Society Commission (March 17, 2025)